NAD

Silver Star Brands Says it Will Discontinue ‘JuniorSlim’ Supplement in Response to NAD Inquiry

Silver Star Brands, maker of the “JuniorSlim” dietary supplement, said in response to a National Advertising Division inquiry that it intended to discontinue the product.

Read More

NARB Recommends Novartis/GSK Discontinue Claim that Benefiber ‘Helps Maintain Regularity’

A NARB panel has recommended that Novartis Consumer Health, Inc., now a GSK Consumer Healthcare Company, discontinue the claim, made in television and print ads, that its dietary supplement product Benefiber “Helps Maintain Regularity.”

Read More

NAD Recommends American Dryer Discontinue Claims Challenged by Kimberly-Clark, Including ‘Germ Killing’ Claims

NAD has recommended that American Dryer, Inc., discontinue challenged advertising claims for the company’s ExtremeAir CPC Commercial Jet Air Hand Dryers, including claims that state or imply the product kills pathogens such as E. Coli, Influenza A, Staph and others. The claims at issue were challenged by Kimberly-Clark Corporation.

Read More

Following NAD Inquiry, BrainFire Says it Will Discontinue Claims for Cognitive Supplement

BrainFire, maker of a dietary supplement promoted as a product designed to improve “all areas of cognitive growth,” said it will voluntarily and permanently discontinue advertising claims for its BrainFire supplement identified in a National Advertising Division inquiry.

Read More

NAD Recommends Vital gNetics Discontinue Certain Claims for FlexSure Supplement, Finds Company can Support Certain Claims

NAD has recommended that Vital g-NETICS discontinue certain claims for the company’s claims for the company’s FlexSure Restorative Joint Health dietary supplement, including claims the product is “clinically proven” to be effective. NAD found, however, that the advertiser could support a claim that clinical trials showed that product users “had significant increases in joint comfort, mobility and flexibility.”

Read More

NAD/NARB Filing Fees to Increase, Effective Feb. 1, 2016

Effective Feb. 2, 2016, filing fees for challenges at the National Advertising Division or NARB appeals will increase.

Read More